LillyDirect's 45-day rule, in real numbers
If you buy Zepbound single-dose vials through LillyDirect at the self-pay price, one late refill can move your monthly cost from $449 to somewhere between $599 and $1,049, depending on your dose. The trigger is a condition that most buyers never read closely, known as the 45-day refill window. This article sets out the dose-by-dose numbers, states where each one comes from, and marks how far you should trust it.
DoseTruth is a price-comparison publisher: it is not a pharmacy, not a telehealth provider, and it does not prescribe or dispense any medication. This article is for general information about published prices and is not medical advice, so speak to a licensed clinician or pharmacist before making any decision about a prescription medicine. Every price below was checked on 17 September 2026 against the sources listed at the end, and drug prices change, so confirm the live figure before you buy.
What is LillyDirect's 45-day rule?
The 45-day rule is a condition of Lilly's Zepbound Self Pay Journey Program that keeps the discounted vial price only if you complete each refill within 45 days of the delivery date of your previous shipment. It applies to the 7.5mg, 10mg, 12.5mg and 15mg single-dose vials. The 2.5mg and 5mg starter vials sit on flat prices of $299 and $399 a month and carry no window, so they cannot trigger the penalty at all.
Lilly describes the mechanism plainly in its own announcement. The 25 February 2025 press release says the programme "reduces the price of the 7.5 mg ($599) and 10 mg ($699) doses to $499 per month at first fill and refills that occur within 45 days of prior delivery". Two details in that sentence do the damage. The first fill is always discounted, so nobody meets the higher price on day one, and the clock is measured from delivery, not from the day you place your next order.
The discounted prices have since fallen. On 1 December 2025 Lilly cut the Self Pay Journey price for every affected dose to $449 a month, and dropped the 2.5mg and 5mg tiers to $299 and $399. The published standard self-pay prices behind the window, however, did not move. Those standard prices are what you pay when a refill lands more than 45 days after your last delivery.
| Dose | Self Pay Journey price, within 45 days | Standard price, window missed | 45-day window applies |
|---|---|---|---|
| 2.5mg | $299 | $299 (flat) | No |
| 5mg | $399 | $399 (flat) | No |
| 7.5mg | $449 | $599 | Yes |
| 10mg | $449 | $699 | Yes |
| 12.5mg | $449 | $849 | Yes |
| 15mg | $449 | $1,049 | Yes |
How much does one missed refill cost, dose by dose?
One missed window raises that single month's cost by $150 at 7.5mg and by as much as $600 at 15mg. The penalty is not a flat surcharge. It is the gap between the discounted $449 and the standard list price for your dose, so the higher your maintenance dose, the harder the miss lands. A person on 15mg who slips past the window once pays $1,049 instead of $449 for that month, an increase of $600, or roughly 134 per cent.
| Dose | Within window | Window missed | Extra for that month | Increase |
|---|---|---|---|---|
| 7.5mg | $449 | $599 | $150 | 33 per cent |
| 10mg | $449 | $699 | $250 | 56 per cent |
| 12.5mg | $449 | $849 | $400 | 89 per cent |
| 15mg | $449 | $1,049 | $600 | 134 per cent |
Set against a year, the picture holds its shape. Twelve refills at $449 come to $5,388 for any dose from 7.5mg upward. A single missed month at 15mg lifts that year to $5,988. If deliveries ran late every single month at 15mg, which is unlikely because the first fill is always discounted, the theoretical ceiling would be $12,588, about $7,200 more than the in-window total. The realistic risk is not the ceiling. It is the occasional slip that quietly adds a few hundred dollars with no refund and no warning email that names the figure in advance.
Why is the 45-day window easier to miss than it sounds?
The window is easy to miss because the clock starts on the delivery date of your last shipment, not on the day you place your next order, so shipping time and any prescriber or pharmacy delay all count against you. A month's Zepbound supply is four once-weekly vials, which covers about 28 days of dosing. Measured from the delivery date, a 45-day window therefore leaves a margin of roughly 17 days after your supply runs out before the price resets.
That margin is a calculation from the supply length and the window, not a figure Lilly publishes, so treat it as an estimate. It also shrinks in practice. If a reorder needs a fresh prescription check, a payment retry or a few days in transit, the practical buffer is closer to two weeks than to six. Anyone who reorders only once the current box is empty is already close to the edge before a single parcel is delayed.
How often do people actually have gaps in their refills?
Refill gaps in this drug class are common, although no public dataset measures the specific 45-day self-pay breach, so the link between the two is an inference rather than a measurement. A single-centre retrospective study of 2,306 GLP-1 patients at an academic weight-loss clinic, using electronic health records and pharmacy claims from January 2022 to February 2025, found that about half had discontinued therapy by 12 months, with median persistence of 10.7 months.
Two cautions matter here. That study defined discontinuation as a gap longer than 84 days, which is much wider than the 45-day self-pay window, so it does not tell you how many buyers breach the shorter window while staying on the drug. It is also a single clinic, so it may not represent LillyDirect self-pay buyers, who differ from an insured clinic population. What it does show, fairly, is that continuous month-after-month refilling is not the norm for many patients, which is the behaviour the pricing rule quietly rewards.
How reliable are the numbers in this article?
The price figures rest on Lilly's own published releases and are strong, while the behavioural and buffer claims are weaker and are graded as such below. One honest complication is that secondary write-ups disagree on the standard prices. Some consumer blogs report the penalty prices as $599, $699, $849 and $1,049, matching Lilly's February and June 2025 releases, while others report $499 or a flat $699, which appears to confuse the older $499 Journey price with the standard list price. This article anchors on the figures Lilly itself published and flags that disagreement rather than hiding it.
| Claim | Evidence type | Strength |
|---|---|---|
| Journey prices are $299, $399 and $449 | Lilly release plus trade press, cross-checked with 2026 sources | Strong |
| Standard prices are $599 to $1,049 | Lilly February and June 2025 releases, some blogs disagree | Strong on the figure, disputed by weaker sources |
| One missed month adds $150 to $600 | Arithmetic on the two Lilly price sets | Strong, conditional on the standard prices |
| Window runs from delivery date | Lilly press release and programme terms | Strong |
| First fill is always discounted | Lilly press release wording | Strong |
| Practical buffer is about two weeks | Calculation from 28-day supply and 45-day window | Moderate, an estimate not published by Lilly |
| Refill gaps are common | Single-centre peer-reviewed study, 84-day gap definition | Moderate, and indirect to the 45-day rule |
| Buyers are not clearly warned of the figure | Terms are disclosed in fine print, but the dollar jump is not shown up front | Weak, part observation and part opinion |
What can you do about the 45-day window?
You can lower the risk by tracking the delivery date rather than the order date, and by knowing that the 2.5mg and 5mg tiers carry no window at all. None of the steps below is medical advice, and none of them should change a dose, which is a decision for your prescriber. They are logistics only.
- Note the delivery date of each shipment and count 45 days forward, then reorder well before that date rather than when the box is empty.
- Ask your pharmacy or prescriber how long a reorder normally takes, so transit and review time do not eat the margin.
- Remember that a missed window is not permanent. Meeting the timing again on your next fill restores the discounted price, so one slip does not lock you out.
- Compare the self-pay route against your other options before committing, since prices and rules on these products move often. Our running GLP-1 price-route audit and the note on the oral Wegovy price rise track those shifts.
If you want to work out which route fits your dose and budget, our price-route quiz walks through the questions, and you can reach the team through the contact page or from the DoseTruth home page. We do not sell medicine and we take no commission from any pharmacy.
Common questions
Does the 45-day rule apply to every Zepbound vial?
No. It applies only to the 7.5mg, 10mg, 12.5mg and 15mg vials. The 2.5mg and 5mg starter vials are flat-priced at $299 and $399 and have no refill window, so they never trigger the penalty.
When does the 45-day clock start?
It starts on the delivery date of your previous shipment, not the date you place your next order. Lilly's terms measure the window from the delivery or received date of the prior prescription, which is why shipping and review time count against you.
How much does one late refill add at the top dose?
At 15mg the price rises from $449 to $1,049 for that month, an extra $600. That is the largest single-month jump in the range, and it was checked on 17 September 2026 against Lilly's published prices.
Am I removed from the discount if I miss the window once?
No. Missing the window means you pay the standard price for that one refill, but meeting the 45-day timing again on your next fill restores the discounted rate. The miss is per refill, not a permanent removal.
Why do some websites list different penalty prices?
Because several consumer blogs mix up the older $499 Journey price with the standard list prices, or copy each other's errors. This article uses the standard prices Lilly published in February and June 2025, which are $599, $699, $849 and $1,049.
Could these prices change again?
Yes. Lilly has already changed them twice, cutting the Journey price from $499 to $449 in December 2025. Always confirm the current figure on the day you buy, since the numbers here reflect 17 September 2026.
Sources
- Eli Lilly, "Lilly launches additional Zepbound vial doses and offers new savings for self-pay patients", official press release via PR Newswire, 25 February 2025, prnewswire.com
- Eli Lilly press release reprint, all approved Zepbound vial doses and self-pay pricing, 16 June 2025, seekingalpha.com
- Pharmaceutical Executive, "Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients", 1 December 2025, pharmexec.com
- Find Honest Care, "LillyDirect Zepbound cost by dose", updated April 2026, findhonestcare.com (commercial explainer, not a primary source)
- PolarBearMeds, "Missed Your LillyDirect 45-Day Refill Window?", updated 5 August 2026, polarbearmeds.com (commercial explainer, not a primary source)
- Real-world persistence and discontinuation of semaglutide and tirzepatide in an academic obesity clinic, peer-reviewed single-centre study, pmc.ncbi.nlm.nih.gov